156 related articles for article (PubMed ID: 21232817)
1. The effects of APOE on brain activity do not simply reflect the risk of Alzheimer's disease.
Trachtenberg AJ; Filippini N; Cheeseman J; Duff EP; Neville MJ; Ebmeier KP; Karpe F; Mackay CE
Neurobiol Aging; 2012 Mar; 33(3):618.e1-618.e13. PubMed ID: 21232817
[TBL] [Abstract][Full Text] [Related]
2. Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele.
Wishart HA; Saykin AJ; Rabin LA; Santulli RB; Flashman LA; Guerin SJ; Mamourian AC; Belloni DR; Rhodes CH; McAllister TW
Am J Psychiatry; 2006 Sep; 163(9):1603-10. PubMed ID: 16946187
[TBL] [Abstract][Full Text] [Related]
3. Relation of apolipoprotein E polymorphism to clinically diagnosed Alzheimer's disease in the Korean population.
Kim HC; Kim DK; Choi IJ; Kang KH; Yi SD; Park J; Park YN
Psychiatry Clin Neurosci; 2001 Apr; 55(2):115-20. PubMed ID: 11285089
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E gene and early age-related maculopathy: the Atherosclerosis Risk in Communities Study.
Wong TY; Shankar A; Klein R; Bray MS; Couper DJ; Klein BE; Sharrett AR; Folsom AR
Ophthalmology; 2006 Feb; 113(2):255-9. PubMed ID: 16406547
[TBL] [Abstract][Full Text] [Related]
5. The effects of APOE on the functional architecture of the resting brain.
Trachtenberg AJ; Filippini N; Ebmeier KP; Smith SM; Karpe F; Mackay CE
Neuroimage; 2012 Jan; 59(1):565-72. PubMed ID: 21851856
[TBL] [Abstract][Full Text] [Related]
6. Reduced functional brain activity response in cognitively intact apolipoprotein E epsilon4 carriers.
Lind J; Persson J; Ingvar M; Larsson A; Cruts M; Van Broeckhoven C; Adolfsson R; Bäckman L; Nilsson LG; Petersson KM; Nyberg L
Brain; 2006 May; 129(Pt 5):1240-8. PubMed ID: 16537568
[TBL] [Abstract][Full Text] [Related]
7. Effects of APOE on brain white matter microstructure in healthy adults.
Westlye LT; Reinvang I; Rootwelt H; Espeseth T
Neurology; 2012 Nov; 79(19):1961-9. PubMed ID: 23100402
[TBL] [Abstract][Full Text] [Related]
8. Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer's disease: a cross-sectional study.
Trivedi MA; Schmitz TW; Ries ML; Torgerson BM; Sager MA; Hermann BP; Asthana S; Johnson SC
BMC Med; 2006 Jan; 4():1. PubMed ID: 16412236
[TBL] [Abstract][Full Text] [Related]
9. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
[TBL] [Abstract][Full Text] [Related]
10. The effects of APOE-ε4 on the BOLD response.
Trachtenberg AJ; Filippini N; Mackay CE
Neurobiol Aging; 2012 Feb; 33(2):323-34. PubMed ID: 20409610
[TBL] [Abstract][Full Text] [Related]
11. Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease.
Craft S; Teri L; Edland SD; Kukull WA; Schellenberg G; McCormick WC; Bowen JD; Larson EB
Neurology; 1998 Jul; 51(1):149-53. PubMed ID: 9674794
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease patients not carrying the apolipoprotein E ε4 allele show more severe slowing of oscillatory brain activity.
de Waal H; Stam CJ; de Haan W; van Straaten EC; Blankenstein MA; Scheltens P; van der Flier WM
Neurobiol Aging; 2013 Sep; 34(9):2158-63. PubMed ID: 23587637
[TBL] [Abstract][Full Text] [Related]
13. EEG functional connectivity and ApoE genotype in Alzheimer's disease and controls.
Kramer G; van der Flier WM; de Langen C; Blankenstein MA; Scheltens P; Stam CJ
Clin Neurophysiol; 2008 Dec; 119(12):2727-32. PubMed ID: 18848805
[TBL] [Abstract][Full Text] [Related]
14. Rapid detection of apolipoprotein E genotypes in Alzheimer's disease using polymerase chain reaction-single strand conformation polymorphism.
Kamruecha W; Chansirikarnjana S; Nimkulrat E; Udommongkol C; Wongmek W; Thangnipon W
Southeast Asian J Trop Med Public Health; 2006 Jul; 37(4):793-7. PubMed ID: 17121308
[TBL] [Abstract][Full Text] [Related]
15. Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease.
Filippini N; Rao A; Wetten S; Gibson RA; Borrie M; Guzman D; Kertesz A; Loy-English I; Williams J; Nichols T; Whitcher B; Matthews PM
Neuroimage; 2009 Feb; 44(3):724-8. PubMed ID: 19013250
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis.
Neu SC; Pa J; Kukull W; Beekly D; Kuzma A; Gangadharan P; Wang LS; Romero K; Arneric SP; Redolfi A; Orlandi D; Frisoni GB; Au R; Devine S; Auerbach S; Espinosa A; Boada M; Ruiz A; Johnson SC; Koscik R; Wang JJ; Hsu WC; Chen YL; Toga AW
JAMA Neurol; 2017 Oct; 74(10):1178-1189. PubMed ID: 28846757
[TBL] [Abstract][Full Text] [Related]
17. Influence of APOE genotype and the presence of Alzheimer's pathology on synaptic membrane lipids of human brains.
Oikawa N; Hatsuta H; Murayama S; Suzuki A; Yanagisawa K
J Neurosci Res; 2014 May; 92(5):641-50. PubMed ID: 24446209
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein C-I expression in the brain in Alzheimer's disease.
Petit-Turcotte C; Stohl SM; Beffert U; Cohn JS; Aumont N; Tremblay M; Dea D; Yang L; Poirier J; Shachter NS
Neurobiol Dis; 2001 Dec; 8(6):953-63. PubMed ID: 11741391
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.
Marra C; Bizzarro A; Daniele A; De Luca L; Ferraccioli M; Valenza A; Brahe C; Tiziano FD; Gainotti G; Masullo C
Dement Geriatr Cogn Disord; 2004; 18(2):125-31. PubMed ID: 15211066
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease.
Bizzarro A; Marra C; Acciarri A; Valenza A; Tiziano FD; Brahe C; Masullo C
Dement Geriatr Cogn Disord; 2005; 20(4):254-61. PubMed ID: 16103669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
